Fas ligand in human serum (original) (raw)

• Gruss, H.-J. & Dower, S. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphoma. Blood 85, 3378–3404 (1995).
  CAS PubMed Google Scholar
• Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1456 (1995).
  Article CAS PubMed Google Scholar
• Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75, 1169–1178 (1993).
  Article CAS PubMed Google Scholar
• Smith, C.A., Farrah, T. & Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959–962 (1994).
  Article CAS PubMed Google Scholar
• Suda, T. et al. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154, 3806–3813 (1995).
  CAS PubMed Google Scholar
• Vignaux, F. et al. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181, 781–786 (1995).
  Article CAS PubMed Google Scholar
• Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274–1279 (1992).
  CAS PubMed Google Scholar
• Adachi, M. et al. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. Nature Genet. 11, 294–300 (1995).
  Article CAS PubMed Google Scholar
• Adachi, M. et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA (in the press).
• Nagata, S. & Suda, T. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 16, 39–43 (1995).
  Article CAS PubMed Google Scholar
• Griffith, T., Brunner, T., Fletcher, S., Green, D. & Ferguson, T. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189–1192 (1995).
  Article CAS PubMed Google Scholar
• Bellgrau, D. et al. A role for CD9S ligand in preventing graft rejection. Nature 377, 630–632 (1995).
  Article CAS PubMed Google Scholar
• Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).
  Article CAS PubMed Google Scholar
• Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995).
  Article CAS PubMed Google Scholar
• Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994).
  Article CAS PubMed Google Scholar
• Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Sc Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).
  Article CAS PubMed Google Scholar
• Hiramatsu, N. et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354–1359 (1994).
  Article CAS PubMed Google Scholar
• Debatin, K.-M. et al. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83, 3101–3103 (1994).
  CAS PubMed Google Scholar
• Katsikis, P., Wunderlich, E., Smith, C., Herzenberg, L. & Herzenberg, L. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029–2036 (1995).
  Article CAS PubMed Google Scholar
• Falk, M.H. et al. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79, 3300–3306 (1992).
  CAS PubMed Google Scholar
• Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
  Article CAS PubMed Google Scholar
• Fiers, W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199–212 (1991).
  Article CAS PubMed Google Scholar
• Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411–452 (1992).
  Article CAS PubMed Google Scholar
• Mohler, K.M. et al. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370, 218–220 (1994).
  Article CAS PubMed Google Scholar
• McGeehan, G.M. et al. Regulation of tumor necrosis factor-a processing by a metal-loproteinase inhibitor. Nature 370, 558–561 (1994).
  Article CAS PubMed Google Scholar
• Gearing, A.J.H. et al. Processing of tumor necrosis factor-a precursor by metallopro-teinases. Nature 370, 555–557 (1994).
  Article CAS PubMed Google Scholar
• Beutler, B. & Cerami, A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320, 584–588 (1986).
  Article CAS PubMed Google Scholar
• Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129–1135 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Loughran, T.P., Clonal diseases of large granular lymphocytes. Blood 82, 1–14 (1993).
  PubMed Google Scholar
• Takahashi, T. et al. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567–1574 (1994).
  Article CAS PubMed Google Scholar
• Suda, T. & Nagata, S. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179, 873–878 (1994).
  Article CAS PubMed Google Scholar
• Tagawa, S. et al. Transformation of large granular lymphocytic leukemia during the course of a reactive human herpesvirus-6 infection. Leukemia 6, 465–469 (1992).
  CAS PubMed Google Scholar
• Tagawa, S., Hatakeyama, M., Shibano, M., Taniguchi, T. & Kitani, T. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia. Blood 71, 1161–1164 (1988).
  CAS PubMed Google Scholar
• Kagi, D. et al. Fas and perform pathway as major mechanisms of T cell-mediated cvtotoxicity. Science 265, 528–530 (1994).
  Article CAS PubMed Google Scholar
• Kojima, H. et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1, 357–364 (1994).
  Article CAS PubMed Google Scholar
• Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J., T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650–652 (1994).
  Article CAS PubMed Google Scholar
• Kataoka, T. et al. Acidification is essential for maintaining the structure and function of lytic granules of CTL. J. Immunol. 153, 3938–3947 (1994).
  CAS PubMed Google Scholar
• Chehimi, J. et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789–796 (1992).
  Article CAS PubMed Google Scholar
• Iwai, K. et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84, 1201–1208 (1994).
  CAS PubMed Google Scholar
• Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31–37 (1994).
  Article CAS PubMed Google Scholar
• Arase, H., Arase, N. & Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235–1238 (1995).
  Article CAS PubMed Google Scholar
• Leithauser, F. et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415–429 (1993).
  CAS PubMed Google Scholar
• Owen-Schaub, L.B., Meterissian, S. & Ford, R.J. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J. Immunother. 14, 234–241 (1993).
  Article CAS Google Scholar
• Gumperz, J.E. & Parham, P. The enigma of the natural killer cell. Nature 378, 245–248 (1995).
  Article CAS PubMed Google Scholar
• Yokoyama, W. Natural killer cell receptors specific for major rustocompatibility complex class I molecule. Proc. Natl. Acad. Sci. USA 92, 3081–3085 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Ameisen, J., Estaquier, J., Idziorek, T. & De Bels, F. Programmed cell death and AIDS: Significance, perspective and unanswered questions. Cell Death Differ. 2, 9–22 (1995).
  CAS PubMed Google Scholar
• Gougeon, M. Does apoptosis contribute to CD4 T cell depletion in human immunodeficiency virus infection? Cell Death Differ. 2, 1–8 (1995).
  CAS PubMed Google Scholar
• Enari, M., Hug, H. & Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78–81 (1995).
  Article CAS PubMed Google Scholar
• Clare, J.J. et al. Production of mouse epidermal growth factor in yeast: High-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 105, 205–212 (1991).
  Article CAS PubMed Google Scholar
• Mizushima, S. & Nagata, S. pEF-BOS: A powerful mammalian expression vector. Nucleic Acids Res. 18, 5322 (1990).
  Article CAS PubMed PubMed Central Google Scholar